Advance Search | Bentham Science

Effects of Physical Exercise on Depressive Symptoms and Biomarkers in Depression

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 10 Year: 2014 Page: 1640-1653
Author(s): Trevor Archer,Torbjorn Josefsson,Magnus Lindwall

Novel Therapeutic Targets in Neuropsychiatric Disorders: The Neuroepigenome

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 1 Year: 2014 Page: 1831-1839
Author(s): Lucio Tremolizzo, Virginia Rodriguez-Menendez, Elisa Conti, Chiara Paola Zoia, Guido Cavaletti, Carlo Ferrarese

Review Article

Disturbed Tryptophan Metabolism in Cardiovascular Disease

Journal: Current Medicinal Chemistry
Volume: 21 Issue: 17 Year: 2014 Page: 1931-1937
Author(s): H. Mangge,I. Stelzer,E.Z. Reininghaus,D. Weghuber,T.T. Postolache,D. Fuchs

Gut Emotions - Mechanisms of Action of Probiotics as Novel Therapeutic Targets for Depression and Anxiety Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 10 Year: 2014 Page: 1770-1786
Author(s): Anastasiya Slyepchenko,Andre F. Carvalho,Danielle S. Cha,Siegfried Kasper,Roger S. McIntyre

Novel Therapeutic Strategies in Major Depression: Focus on RNAi and Ketamine

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 2 Year: 2014 Page: 3848-3860
Author(s): Analia Bortolozzi, Pau Celada, Francesc Artigas

Late Life Depression: A Diagnostic and Pharmacological Review

Journal: Current Psychopharmacology
Volume: 3 Issue: 1 Year: 2014 Page: 32-41
Author(s): Carol Dillon,Clara Rodriguez,Fernando E. Taragano

Ketamine as Antidepressant? Current State and Future Perspectives

Journal: Current Neuropharmacology
Volume: 12 Issue: 1 Year: 2014 Page: 57-70
Author(s): H. W.W. Hasselmann

Activated Immune System and Inflammation in Healthy Ageing: Relevance for Tryptophan and Neopterin Metabolism

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 6048-6057
Author(s): Lucile Capuron, Simon Geisler, Katharina Kurz, Friedrich Leblhuber, Barbara Sperner-Unterweger, Dietmar Fuchs

Genetically Modified Mice as Tools to Understand the Neurobiological Substrates of Depression

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 2 Year: 2014 Page: 3718-3737
Author(s):

The Akt-mTOR Pathway in Downâs Syndrome: The Potential Use of Rapamycin/Rapalogs for Treating Cognitive Deficits

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 1 Year: 2014 Page: 34-40
Author(s): Jose Antonio Troca-Marin,Juan Jose Casanas,Itziar Benito,Maria Luz Montesinos

Search

Find Journals, Volumes, Issues, Articles, Ebooks and Chapters

Search Result "severe mood dysregulation"